Cost‐effectiveness analysis of new drugs for chronic hepatitis C: The importance of updating utility values
Paolo A. Cortesi, Luciana Scalone, Lorenzo G. Mantovani – 12 July 2014
Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada
Brendan Jacka, Tanya Applegate, Mel Krajden, Andrea Olmstead, P. Richard Harrigan, Brandon D.L. Marshall, Kora DeBeck, M.‐J. Milloy, Francois Lamoury, Oliver G. Pybus, Viviane D. Lima, Gkikas Magiorkinis, Vincent Montoya, Julio Montaner, Jeffrey Joy, Conan Woods, Sabina Dobrer, Gregory J. Dore, Art F.Y. Poon, Jason Grebely – 12 July 2014
LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions
Donald G. Mitchell, Jordi Bruix, Morris Sherman, Claude B. Sirlin – 12 July 2014 – To improve standardization and consensus regarding performance, interpreting, and reporting computed tomography (CT) and magnetic resonance imaging (MRI) examinations of the liver in patients at risk for hepatocellular carcinoma (HCC), LI‐RADS (Liver Imaging Reporting and Data System) was launched in March 2011 and adopted by many clinical practices throughout the world.
Phenotypic alterations of regulatory T cells in autoimmune hepatitis: Causal or associated with treatment and remission?
Marcial Sebode, Moritz Peiseler, Christina Weiler‐Normann, Christoph Schramm, Ansgar W. Lohse, Johannes Herkel – 12 July 2014
LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions
Donald G. Mitchell, Jordi Bruix, Morris Sherman, Claude B. Sirlin – 12 July 2014 – To improve standardization and consensus regarding performance, interpreting, and reporting computed tomography (CT) and magnetic resonance imaging (MRI) examinations of the liver in patients at risk for hepatocellular carcinoma (HCC), LI‐RADS (Liver Imaging Reporting and Data System) was launched in March 2011 and adopted by many clinical practices throughout the world.
To whom goes the kidney?
Jayme E. Locke – 11 July 2014
Reframing the impact of combined heart‐liver allocation on liver transplant wait‐list candidates
David S. Goldberg, Peter P. Reese, Sandra Amaral, Peter L. Abt – 11 July 2014 – Simultaneous heart‐liver (H‐L) transplantation, although rare, has become more common in the United States. When the primary organ is a heart or liver, patients receiving an offer for the primary organ automatically receive the second, nonprimary organ from that donor. This policy raises issues of equity, such as whether liver transplantation alone candidates bypassed by H‐L recipients are disadvantaged.
Is there an ideal cutoff for α‐fetoprotein as an exclusion criterion for liver transplantation?
Angelo Alves Mattos, Luciana Santos Schraiber, Maria Lucia Zanotell, Guido Cantisani – 11 July 2014
Comparing living donor and deceased donor liver transplantation: A matched national analysis from 2007 to 2012
Richard S. Hoehn, Gregory C. Wilson, Koffi Wima, Samuel F. Hohmann, Emily F. Midura, E. Steve Woodle, Daniel E. Abbott, Ashish Singhal, Shimul A. Shah – 11 July 2014 – A complete evaluation of living donor liver transplantation (LDLT) in the United States has been difficult because of the persistent low volume and the lack of adequate comparisons with deceased donor liver transplantation (DDLT). Recent reports have suggested outcomes equivalent to those for DDLT, but these studies did not adjust for differences in recipient selection.
Reply
Kaoru Tsuchiya, Yasuhiro Asahina, Masayuki Kurosaki, Nobuyuki Enomoto, Namiki Izumi – 11 July 2014